B Positive – all you wanted to know about - ASHM

More documents

Recommendations

Info

Appendix 2 – Continued Centers for Disease Control and Prevention – national centre for HiV, Viral Hepatitis, std, and tb Prevention Web: www.cdc.gov » Viral Hepatitis b – facts and educational materials http://www.cdc.gov/ncidod/diseases/hepatitis/b/index.htm » Viral Hepatitis b: frequently asked Questions http://www.cdc.gov/ncidod/diseases/hepatitis/b/faqb.htm Hepatitis B Foundation Web: www.hepb.org » ‘Living with Hepatitis b’ – information and resources on hepatitis b http://www.hepb.org/living/index.htm New Zealand Society of Gastroenterology – provides resources and information on liver disease to health professionals and consumers Web: www.nzsg.org.nz Think B, Hepatitis B and Asian Americans – provides information on chronic infections among asianamerican populations Web: www.thinkb.org World Health Organization Factsheet (WHO) Web: www.who.int/en » Hepatitis b – fact sheet and information http://www.who.int/mediacentre/factsheets/fs204/en/index.html b Positive – all you wanted to know about hepatitis b: a guide for primary care providers 113
GLOSSARY AND ABBREVIATIONS Viral hepatitides HAV: hepatitis a virus HBV: hepatitis b virus HCV: hepatitis c virus HDV: hepatitis d (delta) virus HEV: hepatitis e virus Ab: antibody An immunoglobulin essential to the immune system, produced in response to bacteria or viruses. In the case of hepatitis B, antibodies are produced in response to the virus AFP: alphafetoprotein Elevated values may indicate active cirrhosis or hepatocellular carcinoma Ag: antigen A substance (usually a protein) that causes the formation of an antibody and reacts specifically with that antibody AIDS: acquired immune deficiency syndrome ALP: alkaline phosphatase ALT: alanine aminotransferase An enzyme which may indicate liver damage when found in high levels in the blood. Also known as serum glutamic pyruvic transaminase (SGPT) Antiviral resistance: The selection of antiviral-resistant mutations usually in association with the use of antiviral drugs. The rate at which resistant mutants are selected in HBV depends on various factors including: pretreatment serum HBV DNA levels; rapidity of viral suppression; duration of treatment; prior exposure to NA therapy. The first indication of resistance is virological breakthrough (10-fold [1 log] increase in serum HBV DNA above nadir after achieving virological response during treatment), followed by biochemical breakthrough (increase in ALT above ULN after achieving normalisation during treatment) AST: aspartate aminotransferase An enzyme normally present in liver and heart cells, which may indicate liver damage when found in high levels in the blood. Also known as serum glutamic oxaloacetic transaminase (SGOT) B-cell: A type of immune cell Biochemical markers of liver disease Include ALT, AST, GGT and ALP. Elevated levels of these markers may indicate liver damage (note that ALT and AST can also rise in other medical conditions). The upper limit of normal levels varies depending on the laboratory used CALD: Culturally and Linguistically Diverse communities 114 b Positive – all you wanted to know about hepatitis b: a guide for primary care providers
Page 1 and 2:
all you wanted to know about hepati
Page 3 and 4:
B Positive - all you wanted to know
Page 5 and 6:
4 b Positive - all you wanted to kn
Page 7 and 8:
Foreword in nsW, just seven cancers
Page 9 and 10:
Executive Summary this monograph ai
Page 11 and 12:
Executive Summary variable course o
Page 13 and 14:
Executive Summary of the exposed he
Page 15 and 16:
5 Figures and 2 Tables 1 Prevalence
Page 17 and 18:
1 Prevalence and epidemiology of he
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
VIROLOGY: VIRAL REPLICATION AND DRU
Page 27 and 28:
2 Virology: viral replication and d
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
3 Hepatitis B virus testing and int
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
References 1. Milich d, Liang tJ. e
Page 41 and 42:
NATURAL HISTORY OF CHRONIC HEPATITI
Page 43 and 44:
4 Natural history of chronic hepati
Page 45 and 46:
4 Natural history of chronic hepati
Page 47 and 48:
PRIMARY PREVENTION OF HEPATITIS B V
Page 49 and 50:
5 Primary prevention of hepatitis B
Page 51 and 52:
5 Primary prevention of hepatitis B
Page 53 and 54:
6 Clinical assessment of patients w
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
7 Treatment of chronic hepatitis B
Page 61 and 62:
7 Treatment of chronic hepatitis B
Page 63 and 64: 7 Treatment of chronic hepatitis B
Page 65 and 66: 7 Treatment of chronic hepatitis B
Page 67 and 68: 8 Managing patients with advanced l
Page 69 and 70: 8 Managing patients with advanced l
Page 71 and 72: 9 Hepatitis B virus related hepatoc
Page 77 and 78: 10 Managing hepatitis B virus infec
Page 83 and 84: INFECTION CONTROL AND OCCUPATIONAL
Page 85 and 86: 11 Infection control and occupation
Page 91 and 92: PRIVACY, CONFIDENTIALITY AND OTHER
Page 93 and 94: 12 Privacy, confidentiality and oth
Page 95 and 96: 12 Privacy, confidentiality and oth
Page 97 and 98: THE ROLE OF COMPLEMENTARY MEDICINE
Page 99 and 100: 13 The role of complementary medici
Page 101 and 102: 13 The role of complementary medici
Page 103 and 104: Appendix 1 Hepatitis B Fact sheet -
Page 105 and 106: Appendix 1 - Continued support is a
Page 107 and 108: Appendix 2 List of useful organisat
Page 109 and 110: Appendix 2 - Continued » Hepatitis
Page 111 and 112: Appendix 2 - Continued The Hepatiti
Page 113: Appendix 2 - Continued otHer onLine
Page 117 and 118: Glossary and abbreviations GP: Gene
Page 119 and 120: Glossary and abbreviations Standard
Page 121 and 122: Index • HBV DNA level............
Page 123 and 124: Index liver transplantation........
Page 125: Notes 1 4 b Positive - all you want
show all

B Positive – all you wanted to know about - ASHM

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?